Carcinoma of pancreas
- Synonyms
- Exocrine pancreatic carcinoma; PANCREATIC ACINAR CARCINOMA; PANCREATIC CARCINOMA; Pancreatic cancer, somatic; Pancreatic carcinoma, somatic
- Modes of inheritance
- Not genetically inherited (Orphanet)
Summary
Available tests
Check Related conditions for additional relevant tests.
Clinical tests (244 available)
Cytogenetics Tests
Genes See tests for all associated and related genes
Also known as: ACTRIB, ACVRLK4, ALK4, SKR2, ACVR1B
Summary: activin A receptor type 1BAlso known as: 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, K-Ras, K-Ras 2, KI-RAS, KRAS1, KRAS2, NS, NS3, OES, RALD, RASK2, c-Ki-ras, c-Ki-ras2, KRAS
Summary: KRAS proto-oncogene, GTPaseAlso known as: DPC4, JIP, MADH4, MYHRS, SMAD4
Summary: SMAD family member 4Also known as: LKB1, PJS, hLKB1, STK11
Summary: serine/threonine kinase 11Also known as: BCC7, BMFS5, LFS1, P53, TRP53, TP53
Summary: tumor protein p53
Clinical features
Help- Abnormality of the digestive system
- Neoplasm of the pancreas
Neoplasm of the pancreas
- MedGen UID: 18279
- Concept ID: C0030297
- Finding: Neoplastic Process
Abnormality of the digestive system
- Neoplasm of the pancreas
- Abnormality of the genitourinary system
- Increased level of L-fucose in urine
Increased level of L-fucose in urine
- MedGen UID: 1646743
- Concept ID: C4703633
- Finding: Finding
Abnormality of the genitourinary system
- Increased level of L-fucose in urine
- AHRQ, 2013Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.